The Triple Test and Down Syndrome: between Feticide and Therapeutic Abortion
Autori:
Emil ANTON, Alin CIOBICA, Ramona MIRCEA, Nicolae IOANID,
Manuela PADURARIU, Bogdan DOROFTEI,
Dumitru FILIPEANU, Carmen ANTON
Cod: ISSN: 1583-3410 (print), ISSN: 1584-5397 (electronic)
Dimensiuni: pp. 182-189
How to cite this article:Anton, E., Ciobica, A., Mircea, R., Ioanid, N., Padurariu, M., Doroftei, B., Filipeanu, D., Anton, C. (2016). The Triple Test and Down Syndrome: between Feticide and Therapeutic Abortion. Revista de Cercetare si Interventie Sociala, 54, 182-189. |
Abstract:
Down syndrome (DS) or Down’s syndrome, also known as trisomy 21, is a
genetic disorder caused by the presence of all or part of a third copy of chromosome
21. Down syndrome is the most common chromosome abnormality in
humans and represents a complex multifaceted disorder with multiple medical
and bioethical implications. Thereby, it is typically associated with physical
growth delays, a particular set of facial characteristics and an important degree of
intellectual disability. The average full-scale IQ of young adults with Down
syndrome is around 50. A number of tests can be used to screen for Down
syndrome, with varying levels of accuracy and invasiveness. Several blood markers
can be measured that can be used as part of combined tests to predict the risk
of Down syndrome. Abortion after 12 weeks and called therapeutic abortion may
be performed only due to precise medical cause. Down syndrome is not included
in the categories of conditions that justify interruption of the pregnancy by
therapeutic grounds. Still, most parents decide the interruption of the pregnancy
in the case of finding out about the probability of having a child with Down
syndrome.
Keywords:
Down syndrome, triple test, genetic disorders, education.
Download: The Triple Test and Down Syndrome: between Feticide and Therapeutic Abortion
< Anterior |
---|